Search - tctmd.com

Displaying 61 - 80 of 161

Sort: Relevancy | Date

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

ESC Releases Guidance on How to Address CVD in COVID-19 Era

Yael L. Maxwell

November 17, 2021

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

Presentation TCT 2021

Evidence Gaps: What’s Needed in the New Guidelines?

Presenter: Rasha Al-Lamee

November 05, 2021

Presentation TCT 2021

Debate 2: Con – The ISCHEMIA Results Apply to All Revascularization; We All Need to Reconsider Our Approach

Presenter: Sripal Bangalore

November 04, 2021

Presentation TCT 2021

Debate 2: Pro – The ISCHEMIA Trial Results Do Not Apply to CABG; Our Outcomes Are Different!

Presenter: Mario Gaudino

November 04, 2021

Presentation TCT 2021

Debate 1: Con – Anatomy First; NICE Guidelines Got It Right

Presenter: Nick Curzen

November 04, 2021

Presentation TCT 2021

Debate 1: Pro – Functional Testing Matters; We Need to Follow the ACC/AHA Guidelines

Presenter: Raymond Kwong

November 04, 2021

Presentation TCT 2021

What’s Next for Chronic Coronary Syndromes? Upcoming Clinical Trials

Presenter: Christopher Rajkumar

November 04, 2021

Presentation TCT 2021

Quality of Life Matters to Patients: How ISCHEMIA and ORBITA Have Informed Our Practice

Presenter: Suzanne Arnold

November 04, 2021

Presentation TCT 2021

The ISCHEMIA Sub-studies: Highlights and Take-Home Messages

Presenter: David Maron

November 04, 2021

News Daily News

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

Shelley Wood

November 01, 2021

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

News Daily News

COVID-19 Infection Boosts Acute MI, Stroke Risk in Early Weeks

L.A. McKeown

August 03, 2021

News Daily News

Complete Revascularization Best for Most ACS Patients With MVD

Michael O'Riordan

June 25, 2021

News Daily News

Periprocedural MIs Associated With PCI Prognostically Relevant: ESC/EAPCI

Michael O'Riordan

June 10, 2021

News Conference News ACC 2021

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Caitlin E. Cox

May 25, 2021

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

Advertisement

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

ESC Releases Guidance on How to Address CVD in COVID-19 Era

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Evidence Gaps: What’s Needed in the New Guidelines?

Debate 2: Con – The ISCHEMIA Results Apply to All Revascularization; We All Need to Reconsider Our Approach

Debate 2: Pro – The ISCHEMIA Trial Results Do Not Apply to CABG; Our Outcomes Are Different!

Debate 1: Con – Anatomy First; NICE Guidelines Got It Right

Debate 1: Pro – Functional Testing Matters; We Need to Follow the ACC/AHA Guidelines

What’s Next for Chronic Coronary Syndromes? Upcoming Clinical Trials

Quality of Life Matters to Patients: How ISCHEMIA and ORBITA Have Informed Our Practice

The ISCHEMIA Sub-studies: Highlights and Take-Home Messages

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

COVID-19 Infection Boosts Acute MI, Stroke Risk in Early Weeks

Complete Revascularization Best for Most ACS Patients With MVD

Periprocedural MIs Associated With PCI Prognostically Relevant: ESC/EAPCI

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content